Last edition
News about "Clinical Trials"
Advarra Launches Comprehensive Solution to Improve Collaboration on Clinical Trials
The new offering combines the Longboat technology acquired by Advarra in 2020, which now has over 225,000 users, with Advarra's study startup delivery program and industry-adopted single sign-on capabilities.
Clinical Trials | 22/01/2025 | By Aishwarya
Biofidelity and CellCarta Announce Partnership to Enhance NSCLC Clinical Trials with Aspyre Lung
Aspyre Lung simplifies the detection of established non-small cell lung cancer (NSCLC) biomarkers by analysing both DNA and RNA from tissue and blood using a streamlined four-step workflow.
Clinical Trials | 17/01/2025 | By Abha
Unravel Biosciences and PECET to Conduct Clinical Trials of RVL-001 in Rett Syndrome in Colombia
Unravel's proprietary BioNAV drug discovery platform identified RVL-001 as a potentially promising therapeutic drug for Rett Syndrome and PTHS.
Clinical Trials | 25/10/2024 | By Aishwarya | 109
Grit Biotechnology Secures IND Clearance for GT201 from US FDA
GT201, an advanced genetically engineered TIL product developed by Grit Biotechnology's platforms StemTexp and StaViral, boosts T cell survival and function by expressing a vital membrane-bound cytokine complex.
Clinical Trials | 02/09/2024 | By Aishwarya
Merck to Acquire CN201 from Curon Biopharmaceutical
CN201 is currently being evaluated in Phase 1 and Phase 1b/2 clinical trials for treating patients with relapsed or refractory non-Hodgkin’s lymphoma (NHL) and relapsed or refractory B-cell acute lymphocytic leukemia (ALL), respectively.
Clinical Trials | 14/08/2024 | By Aishwarya | 100
Lexicon Selects Medidata to Advance First Non-Opioid Drug for Neuropathic Pain
Medidata has been chosen by Lexicon Pharmaceuticals, Inc. to help advance PROGRESS, a Phase 2b study of LX9211 in diabetic peripheral neuropathic pain (DPNP), with the potential for LX9211 to become the first new, non-opioid drug approved for neuropathic pain in over two decades.
Clinical Trials | 30/05/2024 | By Aishwarya | 113
Parexel Join Hands with Palantir to Boost Clinical Data Delivery for Patients
Parexel has forged a multi-year strategic partnership with Palantir Technologies Inc. to leverage AI to help enhance and accelerate the delivery of safe and effective clinical trials for the world’s biopharmaceutical customers.
Clinical Trials | 29/04/2024 | By Aishwarya | 157
ENTOD Pharma Gets CDSCO Approval for PresVu to Treat Age-Related Vision Impairment
ENTOD Pharmaceuticals has gained approval from the Central Drugs Standard Control Organisation (CDSCO) for PresVu to treat age-related vision impairment.
Clinical Trials | 19/04/2024 | By Aishwarya | 419
Shuttle Pharmaceuticals Completes Manufacturing of Active Pharmaceutical Ingredient (API) for Use in Clinical Trial
Clinical Trials | 04/08/2023 | By Sudeep Soparkar | 338
The new business will offer pharmaceutical development services, including sterile fill-finish
Clinical Trials | 07/09/2022 | By Sudeep Soparkar | 433
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy